Hansoh Pharmaceutical Group Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| General Public | 512,454,713 | 8.65% |
| Institutions | 557,947,407 | 9.42% |
| Individual Insiders | 952,633,250 | 16.1% |
| Private Companies | 3,900,000,000 | 65.8% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 3,900,000,000 | US$8.8b | 0% | no data | |||
| 950,000,000 | US$2.1b | 0% | no data | |||
| 100,921,563 | US$226.9m | 3.67% | 0.01% | |||
| 57,960,361 | US$130.3m | 0% | 0.06% | |||
| 42,095,174 | US$94.6m | -0.86% | no data | |||
| 38,726,168 | US$87.1m | -0.12% | no data | |||
| 33,516,519 | US$75.4m | 0% | 0.11% | |||
| 31,935,182 | US$71.8m | 12.3% | 0.03% | |||
| 31,918,451 | US$71.8m | 0.31% | 0.01% | |||
| 20,700,249 | US$46.5m | 0% | 0.25% | |||
| 20,008,000 | US$45.0m | 0% | 0.24% | |||
| 17,240,000 | US$38.8m | 0% | 0.09% | |||
| 15,412,218 | US$34.7m | -1.96% | no data | |||
| 10,807,108 | US$24.3m | 0% | no data | |||
| 10,670,000 | US$24.0m | 0% | 0.17% | |||
| 10,170,000 | US$22.9m | 0% | 0.11% | |||
| 10,125,129 | US$22.8m | 4.03% | 0.03% | |||
| 5,429,971 | US$12.2m | 0.11% | no data | |||
| 5,412,000 | US$12.2m | 0.59% | no data | |||
| 5,366,081 | US$12.1m | -0.66% | no data | |||
| 5,064,000 | US$11.4m | 0% | 0.29% | |||
| 4,858,000 | US$10.9m | 0% | 0.04% | |||
| 4,408,000 | US$9.9m | 0% | no data | |||
| 4,155,716 | US$9.3m | 0% | 0.1% | |||
| 4,081,084 | US$9.2m | -0.83% | no data |